Cargando…

Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients

BACKGROUND: T helper 17 (Th17) cells can recruit neutrophils to inflammatory sites through production of IL-17, which induces chemokine release. IL-23 is an important inducer of IL-17 and IL-22 production. Our aim was to study the role of Th17 cells in cystic fibrosis (CF) lung disease by measuring...

Descripción completa

Detalles Bibliográficos
Autores principales: Decraene, Ann, Willems-Widyastuti, Anna, Kasran, Ahmad, De Boeck, Kris, Bullens, Dominique M, Dupont, Lieven J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019184/
https://www.ncbi.nlm.nih.gov/pubmed/21143945
http://dx.doi.org/10.1186/1465-9921-11-177
_version_ 1782196180394967040
author Decraene, Ann
Willems-Widyastuti, Anna
Kasran, Ahmad
De Boeck, Kris
Bullens, Dominique M
Dupont, Lieven J
author_facet Decraene, Ann
Willems-Widyastuti, Anna
Kasran, Ahmad
De Boeck, Kris
Bullens, Dominique M
Dupont, Lieven J
author_sort Decraene, Ann
collection PubMed
description BACKGROUND: T helper 17 (Th17) cells can recruit neutrophils to inflammatory sites through production of IL-17, which induces chemokine release. IL-23 is an important inducer of IL-17 and IL-22 production. Our aim was to study the role of Th17 cells in cystic fibrosis (CF) lung disease by measuring IL-17 protein and mRNA levels and IL-22 and IL-23 mRNA in sputum of clinically stable CF patients and by comparing these levels with healthy controls. METHODS: Sputum induction was performed in adult CF patients outside of an exacerbation and healthy control subjects. IL-17A protein levels were measured in supernatants with cytometric bead array (CBA) and RNA was isolated and quantitative RT-PCR was performed for IL-17A, IL-22 and IL-23. RESULTS: We found significantly higher levels of IL-17A protein and mRNA levels (both: p < 0.0001) and IL-23 mRNA levels (p < 0.0001) in the sputum of CF group as compared to controls. We found very low levels of IL-22 mRNA in the CF group. The levels of IL-17 and IL-23 mRNA were higher in patients chronically infected with Pseudomonas aeruginosa (P. aeruginosa) as compared to those who were not chronically infected with P. aeruginosa. The presence of Staphylococcus aureus (S. aureus) on sputum did not affect the IL-17 or IL-23 levels. There was no correlation between IL-17 or IL-23 levels and FEV(1 )nor sputum neutrophilia. CONCLUSION: The elevated levels of IL-17 and IL-23 might indicate that Th17 cells are implicated in the persistent neutrophil infiltration in CF lung disease and chronic infection with P. aeruginosa.
format Text
id pubmed-3019184
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30191842011-01-12 Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients Decraene, Ann Willems-Widyastuti, Anna Kasran, Ahmad De Boeck, Kris Bullens, Dominique M Dupont, Lieven J Respir Res Research BACKGROUND: T helper 17 (Th17) cells can recruit neutrophils to inflammatory sites through production of IL-17, which induces chemokine release. IL-23 is an important inducer of IL-17 and IL-22 production. Our aim was to study the role of Th17 cells in cystic fibrosis (CF) lung disease by measuring IL-17 protein and mRNA levels and IL-22 and IL-23 mRNA in sputum of clinically stable CF patients and by comparing these levels with healthy controls. METHODS: Sputum induction was performed in adult CF patients outside of an exacerbation and healthy control subjects. IL-17A protein levels were measured in supernatants with cytometric bead array (CBA) and RNA was isolated and quantitative RT-PCR was performed for IL-17A, IL-22 and IL-23. RESULTS: We found significantly higher levels of IL-17A protein and mRNA levels (both: p < 0.0001) and IL-23 mRNA levels (p < 0.0001) in the sputum of CF group as compared to controls. We found very low levels of IL-22 mRNA in the CF group. The levels of IL-17 and IL-23 mRNA were higher in patients chronically infected with Pseudomonas aeruginosa (P. aeruginosa) as compared to those who were not chronically infected with P. aeruginosa. The presence of Staphylococcus aureus (S. aureus) on sputum did not affect the IL-17 or IL-23 levels. There was no correlation between IL-17 or IL-23 levels and FEV(1 )nor sputum neutrophilia. CONCLUSION: The elevated levels of IL-17 and IL-23 might indicate that Th17 cells are implicated in the persistent neutrophil infiltration in CF lung disease and chronic infection with P. aeruginosa. BioMed Central 2010 2010-12-10 /pmc/articles/PMC3019184/ /pubmed/21143945 http://dx.doi.org/10.1186/1465-9921-11-177 Text en Copyright ©2010 Decraene et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Decraene, Ann
Willems-Widyastuti, Anna
Kasran, Ahmad
De Boeck, Kris
Bullens, Dominique M
Dupont, Lieven J
Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
title Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
title_full Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
title_fullStr Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
title_full_unstemmed Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
title_short Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients
title_sort elevated expression of both mrna and protein levels of il-17a in sputum of stable cystic fibrosis patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019184/
https://www.ncbi.nlm.nih.gov/pubmed/21143945
http://dx.doi.org/10.1186/1465-9921-11-177
work_keys_str_mv AT decraeneann elevatedexpressionofbothmrnaandproteinlevelsofil17ainsputumofstablecysticfibrosispatients
AT willemswidyastutianna elevatedexpressionofbothmrnaandproteinlevelsofil17ainsputumofstablecysticfibrosispatients
AT kasranahmad elevatedexpressionofbothmrnaandproteinlevelsofil17ainsputumofstablecysticfibrosispatients
AT deboeckkris elevatedexpressionofbothmrnaandproteinlevelsofil17ainsputumofstablecysticfibrosispatients
AT bullensdominiquem elevatedexpressionofbothmrnaandproteinlevelsofil17ainsputumofstablecysticfibrosispatients
AT dupontlievenj elevatedexpressionofbothmrnaandproteinlevelsofil17ainsputumofstablecysticfibrosispatients